Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?
- PMID: 36669147
- PMCID: PMC10043552
- DOI: 10.1200/JCO.22.02605
Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?
Conflict of interest statement
The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
No other potential conflicts of interest were reported.
Comment on
-
Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.J Clin Oncol. 2023 Mar 20;41(9):1684-1694. doi: 10.1200/JCO.22.00826. Epub 2022 Dec 21. J Clin Oncol. 2023. PMID: 36542815 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical